KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Change in Account Payables (2016 - 2017)

Palvella Therapeutics (PVLA) has disclosed Change in Account Payables for 5 consecutive years, with $43000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Change in Account Payables changed N/A to $43000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $2.2 million, a N/A change, with the full-year FY2024 number at $2.2 million, up 199.69% from a year prior.
  • Change in Account Payables was $43000.0 for Q4 2024 at Palvella Therapeutics, down from $1.7 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.7 million in Q3 2024 to a low of $43000.0 in Q4 2024.